Jan Sperveslage

Muenster, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

CuMo-a program to strengthen molecular diagnostics in pathology

CuMo-a program to strengthen molecular diagnostics in pathology

Journal: Pathologie (Heidelberg, Germany)

Published: January 29, 2026

Report of the Molecular Pathology Working Group of the German Society of Pathology

Report of the Molecular Pathology Working Group of the German Society of Pathology

Journal: Pathologie (Heidelberg, Germany)

Published: October 05, 2025

Report of the Molecular Pathology Working Group of the German Society for Pathology

Report of the Molecular Pathology Working Group of the German Society for Pathology

Journal: Pathologie (Heidelberg, Germany)

Published: October 07, 2024

Report of the Molecular Pathology Working Group of the German Society for Pathology

Report of the Molecular Pathology Working Group of the German Society for Pathology

Journal: Pathologie (Heidelberg, Germany)

Published: October 06, 2023

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.

Journal: Oncotarget

Published: November 07, 2022

Recurrent CTNNB1 mutations in craniofacial osteomas.

Recurrent CTNNB1 mutations in craniofacial osteomas.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: August 08, 2021

Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.

Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.

Journal: Oncotarget

Published: June 25, 2021

FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma.

FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma.

Journal: Neuro-oncology practice

Published: April 26, 2021

Unraveling the Molecular Tumor-Promoting Regulation of Cofilin-1 in Pancreatic Cancer.

Unraveling the Molecular Tumor-Promoting Regulation of Cofilin-1 in Pancreatic Cancer.

Journal: Cancers

Published: January 05, 2021

Overexpression and Tyr421-phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells.

Overexpression and Tyr421-phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells.

Journal: Cancer cell international

Published: October 02, 2018

Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.

Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.

Journal: The Journal of pathology

Published: September 16, 2018

Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy.

Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy.

Journal: Oncotarget

Published: April 30, 2018

Showing 1-12 of 29

Last Updated: 09/26/2026